Human cytomegalovirus-associated immunosuppression is mediated through interferon-α

Blood

Volumn 89, Issue 7, 1997, Pages 2443-2452

  Noraz, Nelly ^a   Lathey, Janet L ^a   Spector, Stephen A ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON;

ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; LYMPHOCYTE PROLIFERATION; MONOCYTE; OXIDATION; PHAGOCYTOSIS; PRIORITY JOURNAL; SKIN FIBROBLAST; VIRUS STRAIN;

EID: 0030901561     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.7.2443     Document Type: Article

References (40)

1. McChesney MB, Oldstone MB: Viruses perturb lymphocyte functions: Selected principles characterizing virus-induced immunosuppression. Annu Rev Immunol 5:279, 1987
2. Rinaldo CR, Carney WP, Richter BS, Black PH, Hirsch MS: Mechanisms of immunosuppression in cytomegaloviral mononucleosis. J Infect Dis 141:488, 1980
3. Carney WP, Hirsch MS: Mechanisms of immunosuppression in cytomegalovirus mononucleosis. II. Virus-monocyte interactions. J Infect Dis 144:47, 1981
4. Schrier RD, Rice GP, Oldstone MB: Suppression of natural killer cell activity and T cell proliferation by fresh isolates of human cytomegalovirus. J Infect Dis 153:1084, 1986
5. Kapasi K, Rice GP: Role of the monocyte in cytomegalovirus-mediated immunosuppression in vitro. J Infect Dis 154:881, 1986
6. Rodgers BC, Scott DM, Mundin J, Sissons JG: Monocyte-derived inhibitor of interleukin 1 induced by human cytomegalovirus. J Virol 55:527, 1985
7. Dudding LR, Garnett HM: Interaction of strain AD169 and a clinical isolate of cytomegalovirus with peripheral monocytes: The effect of lipopolysaccharide stimulation. J Infect Dis 155:891, 1987
8. Scott DM, Rodgers BC, Freeke C, Buiter J, Sissons JG: Human cytomegalovirus and monocytes: Limited infection and negligible immunosuppression in normal mononuclear cells infected in vitro with mycoplasma-free virus strains. J Gen Virol 70:685, 1989
9. Buchmeier NA, Cooper NR: Suppression of monocyte functions by human cytomegalovirus. Immunology 66:278, 1989
10. Loh L, Hudson JB: Murine cytomegalovirus-induced immunosuppression. Infect Immun 36:89, 1982
11. Kapasi K, Rice GP: Cytomegalovirus infection of peripheral blood mononuclear cells: Effects on interleukin-1 and -2 production and responsiveness. J Virol 62:3603, 1988
12. van de Berg AP, Meyaard L, Otto SA, van Son WJ, Klompmaker IJ, Mesander G, de Leij LHFM, Miedema F, The TH: Cytomegalovirus infection associated with a decreased proliferative capacity and increased rate of apoptosis of peripheral blood lymphocytes. Transplant Proc 97:936, 1995
13. Koga Y, Tanaka K, Lu Y, Oh-Tsu M, Sasaki M, Kimura G, Nomoto K: Priming of immature thymocytes to CD3-mediated apoptosis by infection with murine cytomegalovirus. J Virol 68:4322, 1994
14. Einhorn L, Ost A: CMV infection of human blood cells. J Infect Dis 149:207, 1984
15. Rice GPA, Schrier RD, Oldstone MBA: CMV infects human lymphocytes and monocytes: Virus expression is restricted to immediate-early gene products. Proc Natl Acad Sci USA 81:6134, 1984
16. Wentworth BB, French L: Plaque assay of cytomegalovirus strains of human origin. Proc Soc Exp Biol Med 135:253, 1897
17. Mosmann T: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 65:55, 1983
18. Steinkamp JA, Wilson JS, Saunders GC, Stewart CC: Phagocytosis: Flow cytometric quantitation with fluorescent microspheres. Science 215:64, 1982
19. Dougherty GJ, McBride WH: Monocyte differentiation in vitro, in Zembala M, Asherson GL (eds): Human Monocytes. San Diego, CA, Academic, 1989, p 49
20. Rouse BT, Horohov DW: Immunosuppression in viral infections. Rev Infect Dis 8:850, 1986
21. De Maeyer E, De Maeyer-Guignard J: Interferons and Other Regulatory Cytokines. New York, NY, Wiley, 1988
22. Fitzgerald-Bocarsly P: Human natural interferon-α producing cells. Pharmacol Ther 60:39, 1993
23. Schrier RD, Oldstone MB: Recent clinical isolates of cytomegalovirus suppress human cytomegalovirus-specific human leukocyte antigen-restricted cytotoxic T-lymphocyte activity. J Virol 59:127, 1986
24. Rakusan TA, Juneja HS, Fleischmann WR: Inhibition of hematopoietic colony formation by human cytomegalovirus in vitro. J Infect Dis 159:127, 1989
25. Fox JC, Griffiths PD, Emery VC: Quantification of human cytomegalovirus DNA using the polymerase chain reaction. J Gen Virol 73:2405, 1992
26. Nieman PE, Reeves W, Ray G, Flournoy N, Lerner KG, Sale GE, Thomas ED: A prospective analysis of interstitial pneumonia and opportunistic viral infection among recipients of allogenic bone marrow grafts. J Infect Dis 136:754, 1977
27. Peterson LR, Balfour HH Jr: Advances in clinical virology. Prog Clin Pathol 8:239, 1981
28. Shanley JD, Pesanti E: Replication of murine cytomegalovirus in lung macrophages: Effect on phagocytosis of bacteria: Immunology 29:1152, 1982
29. Miller SA, Bia FJ, Coleman DL, Lucia HL, Young KR, Root RK: Pulmonary macrophage function during experimental cytomegalovirus interstitial pneumonia. Infect Immun 47:211, 1985
30. Burd EM, Carrigan DR: Human herpesvirus 6 (HHV-6)-associated dysfunction of blood monocytes. Virus Res 29:79, 1993
31. Becton DL, Adams DO, Hamilton TA: Characterization of protein kinase C activity in interferon gamma treated murine peritoneal macrophages. J Cell Physiol 125:481, 1985
32. Kurihara N, Roodman GD: Interferon-alpha and -gamma inhibit interleukin-1-beta stimulated osteoclast-like cell formation in long-term human marrow cultures. J Interferon Res 10:54.1, 1990
33. Heslop HE, Bianchi ACM, Cordingley FT, Turner M, De Mel WCP, Hoffbrand AV, Brenner MK: Effects of interferon a on autocrine growth factor loops in B lymphoproliferative disorders. J Exp Med 172:1729, 1990
34. Sissolak G, Hohhbrand AV, Mehta AB, Ganeshaguru K: Effects of interferon-alpha (IFN) on the expression of interleukin 1-beta (IL-1), interleukin 6 (IL-6), granulocyte-macrophage colony-stimulating factor (GM-CSF) and tumor necrosis factor-alpha (TNF) in acute myeloid leukemia (AML) blasts. Leukemia 6:1155, 1992
35. Aman MJ, Rudolf G, Goldshmitt J, Aulitzky WE, Lam C, Huber C, Peshel C: Type-1 interferons are potent inhibitors of interleukin-8 production in hematopoietic and bone marrow stromal cells. Blood 82:2371, 1993
36. Tilg H, Mier JW, Vogel W, Aulitzky WE, Wiedermann CJ, Vannier E, Huber C, Dinarello CA: Induction of circulating IL1 receptor antagonist by IFN treatment. J Immunol 150:4687, 1993
37. Mutter W, Reddehase MJ, Busch FW, Bühring H, Koszinowski UH: Failure in generating hemopoietic stem cells is the primary cause of death from cytomegalovirus disease in the immunocompromised host. J Exp Med 167:1645, 1988
38. Knox KK, Carrigan DR: In vitro suppression of bone marrow progenitor cell differentiation by human herpes 6 infection. J Infect Dis 165:925, 1992
39. Lagneaux L, Delforge A, Snoeck R, Stryckmans P, Bron D: Decreased production of cytokines after cytomegalovirus infection of marrow-derived stromal cells. Exp Hematol 22:26, 1994
40. Becker S: Influence of interferon on human monocyte to macrophage development. Cell Immunol 84:145, 1984